PTK2 and neoplasm: We propose a regulatory mechanism that involves the suppression of the FAK/Src signaling pathway, which is related to multiple factors associated with tumor progression, such as migration, invasion, and angiogenesis (Figure 11), verifying that the phosphorylation levels of both proteins of interest, FAK and Src, were lower in their phosphorylated (active) form.